Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants
- PMID: 33816087
- PMCID: PMC8009141
- DOI: 10.1016/j.pmedr.2021.101350
Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants
Abstract
With the demand for rapid COVID-19 vaccine development and evaluation, this paper aimed to describe the prevalence and correlates of willingness to participate in COVID-19 vaccine trials among university students in China. A cross-sectional survey with 1912 Chinese university students was conducted during March and April 2020. Bivariate and multivariate analyses were performed to identify variables associated with willingness to participate. The majority of participants (64.01%) indicated willingness to participate in COVID-19 vaccine trials. Hesitancy over signing informed consent documents, concerns over time necessary for participating in a medical study, and perceived COVID-19 societal stigma were identified as deterrents, whereas lower socioeconomic status, female gender, perception of likely COVID-19 infection during the pandemic, and COVID-19 prosocial behaviors were facilitative factors. Further, public health mistrust and hesitancy over signing informed consent documents had a significant interactive effect on vaccine trial willingness. High standards of ethical and scientific practice are needed in COVID-19 vaccine research, including providing potential participants full and accurate information and ensuring participation free of coercion, socioeconomic inequality, and stigma. Attending to the needs of marginalized groups and addressing psychosocial factors including stigma and public health mistrust may also be important to COVID-19 vaccine development and future uptake.
Keywords: COVID-19; China; Vaccine hesitancy; Vaccine trials willingness; Young adult.
© 2021 Published by Elsevier Inc.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Update of
-
Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants.medRxiv [Preprint]. 2020 Jul 14:2020.07.13.20152678. doi: 10.1101/2020.07.13.20152678. medRxiv. 2020. Update in: Prev Med Rep. 2021 Jun;22:101350. doi: 10.1016/j.pmedr.2021.101350. PMID: 32699860 Free PMC article. Updated. Preprint.
Similar articles
-
Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants.medRxiv [Preprint]. 2020 Jul 14:2020.07.13.20152678. doi: 10.1101/2020.07.13.20152678. medRxiv. 2020. Update in: Prev Med Rep. 2021 Jun;22:101350. doi: 10.1016/j.pmedr.2021.101350. PMID: 32699860 Free PMC article. Updated. Preprint.
-
COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.Mult Scler Relat Disord. 2021 Sep;54:103163. doi: 10.1016/j.msard.2021.103163. Epub 2021 Jul 22. Mult Scler Relat Disord. 2021. PMID: 34325399 Free PMC article.
-
COVID-19 vaccine hesitancy among different population groups in China: a national multicenter online survey.BMC Infect Dis. 2022 Feb 14;22(1):153. doi: 10.1186/s12879-022-07111-0. BMC Infect Dis. 2022. PMID: 35164700 Free PMC article.
-
Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey.J Integr Med. 2022 Jan;20(1):34-44. doi: 10.1016/j.joim.2021.10.004. Epub 2021 Oct 26. J Integr Med. 2022. PMID: 34774463 Free PMC article. Review.
-
Influences on clinical trial participation: Enhancing recruitment through a gender lens - A scoping review.Contemp Clin Trials Commun. 2024 Feb 29;38:101283. doi: 10.1016/j.conctc.2024.101283. eCollection 2024 Apr. Contemp Clin Trials Commun. 2024. PMID: 38456181 Free PMC article.
Cited by
-
Willingness to Receive SARS-CoV-2 Vaccination and Associated Factors among Chinese Adults: A Cross Sectional Survey.Int J Environ Res Public Health. 2021 Feb 18;18(4):1993. doi: 10.3390/ijerph18041993. Int J Environ Res Public Health. 2021. PMID: 33670821 Free PMC article.
-
To Vaccinate or Not to Vaccinate-Reasons of Willingness and Reluctance of Students against SARS-CoV-2 Vaccination-An International Experience.Int J Environ Res Public Health. 2022 Oct 27;19(21):14012. doi: 10.3390/ijerph192114012. Int J Environ Res Public Health. 2022. PMID: 36360893 Free PMC article.
-
Predicting the COVID-19 vaccine receive intention based on the theory of reasoned action in the south of Iran.BMC Public Health. 2022 Feb 4;22(1):229. doi: 10.1186/s12889-022-12517-1. BMC Public Health. 2022. PMID: 35120486 Free PMC article.
-
Invited Editorial. COVID-19 Vaccine: Hope and reality.Afr Health Sci. 2020 Dec;20(4):1507-1509. doi: 10.4314/ahs.v20i4.3. Afr Health Sci. 2020. PMID: 34394211 Free PMC article. No abstract available.
-
Attitude of Health Care Workers and Medical Students towards Vaccination against COVID-19.Vaccines (Basel). 2022 Mar 29;10(4):535. doi: 10.3390/vaccines10040535. Vaccines (Basel). 2022. PMID: 35455284 Free PMC article.
References
-
- Ahmed, F., Ahmed, N., Pissarides, C., Stiglitz, J., 2020. Why inequality could spread COVID-19. Lancet Public Heal [Internet] 5(5):e240. Available from: http://dx.doi.org/10.1016/S2468-2667(20)30085-2 PMID: 32247329. - PMC - PubMed
-
- Caprara G.V., Steca P., Zelli A., Capanna C. A new scale for measuring adults’ prosocialness. Eur. J. Psychol. Assess. 2005;21(2):77–89.
-
- Eisenman D.P., Williams M.V., Glik D., Long A., Plough A.L., Ong M. The public health disaster trust scale: Validation of a brief measure. J Public Heal Manag Pract. 2012;18(4):1–8. - PubMed
-
- Harro C.D., Judson F.N., Gorse G.J., Mayer K.H., Kostman J.R., Brown S.J., Koblin B., Marmor M., Bartholow B.N., Popovic V. Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial. J. Acquir. Immune Defic. Syndr. 2004;37(3):1385–1392. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous